Affiliation:
1. Mendeleev University of Chemical Technology of Russia, 125047, Moscow, Russia
Abstract
The review is focused on the etoposide delivery systems based on colloidal carriers, i.e., nanoparticles and micelles made of synthetic and natural polymers. Etoposide, a topoisomerase II inhibitor, occupies an important place in the chemotherapy of a number of tumors; however, its use is often limited due to severe side effects. The application of colloidal delivery systems makes it possible to change the pharmacokinetic parameters of etoposide and increase its accumulation in tumors leading to an increase in the antitumor effect. Of particular interest are stimuli-sensitive systems that respond to specific conditions in the tumor microenvironment, which can significantly increase the selectivity of the drug.
Publisher
The Russian Academy of Sciences
Reference128 articles.
1. Hande K.R. Etoposide: Four decades of development of a topoisomerase II inhibitor // European Journal of Cancer. 1998. V. 34. № 10. P. 1514–1521. https://doi.org/10.1016/S0959-8049(98)00228-7
2. Примерный перечень основных лекарственных средств, 21-й перечень, 2019 г. Копенгаген: Европейское региональное бюро ВОЗ; 2020. Лицензия: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/bitstream/handle/10665/331990/WHO-EURO-2020-476-40211-53802-rus.pdf?sequence=1&isAllowed=y.
3. Agrawal K. Etoposide // xPharm: The Comprehensive Pharmacology Reference. 2007. P. 1–5. https://doi.org/10.1016/B978-008055232-3.61729-5
4. Slevin M.L. The clinical pharmacology of etoposide // Cancer. 1991. V. 67. № S1. P. 319–329. https://doi.org/10.1002/1097-0142(19910101)67: 1+<319::AID-CNCR2820671319>3.0.CO;2-D
5. Montecucco A., Zanetta F., Biamonti G. Molecular mechanisms of etoposide // EXCLI Journal. Leibniz Research Centre for Working Environment and Human Factors. 2015. V. 14. P. 95–108. https://doi.org/10.17179/excli2014-561
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献